RLFFD Stock Price, News & Analysis

RLFFD

Company Description

RELIEF THERAPEUTICS Holding SA (RLFFD) is a biopharmaceutical company focused on delivering innovative treatment options for select specialty and rare diseases. With a commitment to advancing treatment paradigms, the company's portfolio includes marketed products, proprietary platform technologies, and a clinical development pipeline targeting rare metabolic, dermatology, and respiratory diseases. Relief Therapeutics' mission is to provide therapeutic relief to those suffering from rare diseases, supported by an experienced team of biopharma industry leaders.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$47.4M

Market Cap

0.0

Shares outstanding

Latest News

View All

September 15, 2023

0.00%

Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update

earnings

August 30, 2023

0.00%

Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeutics

June 23, 2023

0.00%

RELIEF THERAPEUTICS Holding SA Announces Closing of CHF 5 Million Private Placement

private placement

June 23, 2023

0.00%

Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE(R) in the Middle East

June 20, 2023

0.00%

RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting of Shareholders

June 16, 2023

0.00%

RELIEF THERAPEUTICS Holding SA Announces CHF 5 Million Private Placement

private placement

SEC Filings

View All

No SEC filings available for RLFFD.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...

Frequently Asked Questions

What is the market cap of RLFFD (RLFFD)?

The market cap of RLFFD (RLFFD) is approximately 47.4M. Learn more about what market capitalization means .

What is RELIEF THERAPEUTICS Holding SA focused on?

RELIEF THERAPEUTICS Holding SA is focused on delivering innovative treatment options for select specialty and rare diseases.

What does the company's portfolio consist of?

The company's portfolio includes marketed products, proprietary platform technologies, and a clinical development pipeline targeting rare metabolic, dermatology, and respiratory diseases.

What is RELIEF THERAPEUTICS' mission?

RELIEF THERAPEUTICS' mission is to provide therapeutic relief to those suffering from rare diseases.

Where is RELIEF THERAPEUTICS headquartered?

RELIEF THERAPEUTICS is headquartered in Geneva, with additional offices in Balerna, Switzerland, Offenbach am Main, Germany, and Monza, Italy.

What is the stock symbol for RELIEF THERAPEUTICS?

The stock symbol for RELIEF THERAPEUTICS is RLFFD.

Where can I find more information about RELIEF THERAPEUTICS?

You can visit RELIEF THERAPEUTICS' website at www.relieftherapeutics.com or follow them on LinkedIn and Twitter.